Spontaneous adverse reaction reporting from a pharmacy office;La notificación espontánea de reacciones adversas desde una Oficina de Farmacia

Pharmaceutical Care Espana

Volumn 5, Issue 5, 2003, Pages 226-231

  Salgueiro Vázquez, M Esther ^a   Bermúdez del Sol, Abdel ^b   Llavona Hevia, Ana ^a   Monteserín Fernández, M Soledad ^a   Sánchez Álvarez, Luis ^c   Revuelta Bayod, Pilar ^d   Hidalgo Balsera, Agustin ^d   Manso Rodríguez, Gloria ^d,e  

^a Oficina de Farmacia   (Spain)

^b Becario de la Agencia de Coop Intl   (Spain)

^c Becario Predoctoral FPU   (Spain)

^d Ctr Farmacovigilancia de Asturias   (Spain)

^e UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CARDIOVASCULAR AGENT; DIGOXIN; DRUG; HEPARIN;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ARTICLE; AUTONOMIC NEUROPATHY; BRADYCARDIA; CENTRAL NERVOUS SYSTEM INFECTION; CONFUSION; CONTROLLED STUDY; DELIRIUM; DIARRHEA; DRUG SURVEILLANCE PROGRAM; EPISTAXIS; FACE EDEMA; FEMALE; FLATULENCE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPONATREMIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NAUSEA; PARESTHESIA; PHARMACY; POLYURIA; PRURITUS; RASH; SOMNOLENCE; SPAIN; TACHYCARDIA; URTICARIA; VISUAL DISORDER; VOMITING;

EID: 0242521677     PISSN: 11396202     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sánchez A, García Ortiz A, Carvajal A. Notificación voluntaria de reacciones adversas a medicamentos. En: Farmacoepidemiología. Carvajal A ed. Universidad de Valladolid 1993;61-74.
2. Capella D, Laporte JR. La notificación espontánea de las reacciones adversas a medicamentos. En: Principios de epidemiología del medicamento. Laporte JR, Tognoni G eds. Masson-Salvat 1993; 147-170.
3. Ley 25/1990, de 20 de diciembre, del Medicamento. BOE no 306, de 22 de diciembre de 1990.
4. Madurga M, de Abajo FJ, Mortín-Serrono G, Montero D. El Sistema Español de Farmacovigilancia. En: Nuevos perspectivas de la Farmacovigilancia en España y en la Unión Europea. Grupo IFAS eds. 1998; 37-62.
5. Roberts PI, Booth TG, Wolfson DJ. The community pharmacist and adverse drug reaction monitoring: (1) a historical and geographical perspective. Pharm J 1993; 250: 875-878.
6. Normas y directrices sobre la Farmacovigiloncia en España. Agencia Española del Medicamento. Misterio de Sanidad y Consumo. 2002
7. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21:247-254.
8. Manual de codificación. Sistema Español de Farmacovigilancia. 1996
9. Keith MR, Bellanger-McCleery RA, Fuchs JE. Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Parm 1989; 46: 1809-1812.
10. Gilroy GW, Scollins MJ, Gay CA, Harry DJ, Giannuzzi DF. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm 1990; 47: 1327-1333.
11. Green CF, Mottram DR, Rowe PR, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001; 51: 81-86.
12. Lawson DH. Epidemiology. En: Texbook of adverse reactions. Davies D.M. ed. Oxford Medical Publications. 1991; 5-17.
13. Denham MJ, Barnett NL. Drug Therapy and older person, Role of the pharmacist. Drug Saf 1998; 19: 243-250.
14. Cruwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cardoret C, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116.
15. Gowdey CW, Brennam M. Adverse drug reaction reporting program of the Ontario Medical Association: the first 3 years. Can Med Assoc J 1985; 132: 19-23.
16. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting-part I. Advers Drug React Ac Pois Rev 1985; 4: 213-230.
17. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting-part II. Advers Drug React Ac Pois Rev 1986; 4: 23-55.
18. Leape LL, Cullen DJ, Dempsey M, Burdick E, Demonaco HJ, Erickson JI, Bates DW. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-270.
19. Tully MP, Seston EM. Impact or pharmacists providing a prescription review and monitoring service in ambulatory care or community practice. Ann Pharmacother 2000; 34: 1320-1331.
20. Egberts TCG, Smulders M, de Koning FHP, Meyboom RHB, Leufkens HGM. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. Br M J 1996; 313: 530-531.
21. Jarernsiripornkul N, Krska J, Capps PAG, Richards RME, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol 2002; 53: 318-325.
22. Jarernsiripornkul N, Krska J, Richards RME, Capps PAG. Pharmacist-assisted patient-reporting of adverse drug reactions. Pharm J 1998; 261: R33.